The asynchronous nature of dystrophic regeneration presumably hampers stage-specific control, as does dysregulation due to persistent dystrophin deficiency (shown for miR-31 [65]), but despite these factors, dystrophic myonuclei demonstrably continue to produce dp427 mRNA. This evidence concerns the gene DMD and hyperinsulinemic hypoglycemia, familial, 4.